Effect of Cnidii Rhizoma on Proliferation of Breast Cancer Cell, Nitric Oxide Production and Ornithine Decarboxylase Activity |
Nam, Kyung-Soo
(Intractable Diseases Research Center and Department of Pharmacology, College of Medicine, Dongguk University)
Son, Ok-Lye (Intractable Diseases Research Center and Department of Pharmacology, College of Medicine, Dongguk University) Lee, Kyung-Hwa (Intractable Diseases Research Center and Department of Pharmacology, College of Medicine, Dongguk University) Cho, Hyun-Jung (Intractable Diseases Research Center and Department of Pharmacology, College of Medicine, Dongguk University) Shon, Yun-Hee (Intractable Diseases Research Center and Department of Pharmacology, College of Medicine, Dongguk University) |
1 | Huber, M. and Poulin, R. (1996) Permissive role of polyamines in the cooperative action of estrogens and insulin or insulin-like growth factor I on human breast cancer cell growth. J. Clin. Endocrinol. Metab. 81: 113-123 DOI PUBMED |
2 | 李尙仁(1998) 本草學, 407-409, 修書院, 서울 |
3 | Macchiarini, P., Fontanini, G., Hardin, M. J., Squartini, F., and Angeletti, C. A. (1992) Relation of neovascularization to metastasis of non-small-cell lung cancer. Lancet 340: 145-146 DOI ScienceOn |
4 | Ambs, S., Bennett, W. P., Merriam, W. G., Ogunfusika, M. 0., Oser, S. M., Harrington, A. M., Shields, P. G., FelleyBosco, E., Hussain, S. P., and Harris, C. C. (1999) Relationship between p53 mutations and inducible nitric oxide synthase expression in human colorectal cancer. J. Natl. Cancer Inst. 91: 86-88 DOI ScienceOn |
5 | Vakkala, M., Kahlos, K., Lakari, E., Paakko, P., Kinnula, V., and Soini, Y. (2000) Inducible nitric oxide synthase expression, apoptosis, and angiogenesis in situ and invasive breast carcinomas. Clin. Cancer Res. 6: 2408-2416 |
6 | Tamir, S. and Tannenbaum, S. R. (1996) The role of nitric oxide(NO) in the carcinogenic process. Biochim. Biophys. Acta 1288: F31-F36 |
7 | Knowles, R. G. and Moncada, S. (1994) Nitric oxide synthases in mammals. Biochem. J. 298: 249-258 |
8 | Li, L., Carol, T., and Susan, K. G. (2000) Inhibition of ornithine decarboxylase (ODC) decreases tumor vascularization and reverse spontaneous tumors in ODClRas transgenic mice. Cancer Res. 60: 5696-5730 |
9 | Kroncke, K. D., Fehsel, K., Suschek, C., and Kolb-Bachofen, V. (2001) Inducible nitric oxide synthase-derived nitric oxide in gene regulation, cell death and cell survival. Int. Immunopharmacol. 1: 1407-1420 DOI ScienceOn |
10 | Suh, N., Glasebrook, A. L., Palkowitz, A. D., Bryant, H. U., Burris, L. L., Starling, J. J., Pearce, H. L., Williams, C., Peer, C., Wang, Y., and Sporn, M. B. (2001) Arzoxifene, a new selective estrogen receptor modulator for chemoprevention of experimental breast cancer. Cancer Res. 61: 8412-8415 |
11 | Green, J. E., Shibata, M. A., Shibata, E., Moon, R. C., Anver, M. R., Kelloff, G., and Lubet, R. (2001) 2-Difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 TIt-antigen transgenic mice. Cancer Res. 61: 7449-7455 |
12 | Felley-Bosco, E. (1998) Role of nitric oxide in genotoxicity: implication for carcinogenesis. Cancer Metastasis Rev. 17: 25-37 DOI ScienceOn |
13 | Robbins, R. A., Barnes, P. J., Springall, D. R., Warren, J. B., Kwon, O. J., Buttery, L. D., Wilson, A. J., Geller, D. A., and Polak, J. M. (1994) Expression of inducible nitric oxide in human lung epithelial cells. Biochem. Biophys. Res. Comm. 203: 209-218 DOI ScienceOn |
14 | Manni, A., Astrow, S. H., Gammon, S., Thompson, J., Mauger, D., and Washington, S. (2001) Immunohistochemical detection of ornithine-decarboxylase in primary and metastatic human breast cancer specimens. Breast Cancer Res. Treat. 67: 147-156 DOI ScienceOn |
15 | Wink, D. A., Hanbauer, I., Grisham, M. B., Laval, F., Nims, R. W., Laval, J., Cook, J., Pacelli, R., Liebmann, I., Krishna, M., Ford, P. C., and Mitchell, J. B. (1996) Chemical biology of nitric oxide: regulation and protective and toxic mechanisms. Curro Top. Cell Regul. 34: 159-187 DOI |
16 | Thomsen, L. L., Miles, D. W., Happerfield, L., Bobrow, L. G., Knowles, R. G., and Moncada, S. (1995) Nitric oxide synthase activity in human breast cancer. Br. J. Cancer 72: 41-44 DOI ScienceOn |
17 | Glikman, P., Vegh, I., Pollina, M. A., Mosto, A. H., and Levy, C. M. (1987) Ornithine decarboxylase activity, prolactin blood levels, and estradiol and progesterone receptors in human breast cancer. Cancer (Phila) 60: 2237-2243 DOI ScienceOn |
18 | Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K, Kavanah, M., Cronin, W. M., Voge~, V, Robidoux, A., Dirnitrov, N., Atkins, J., Daly, M., Wieand, S., Tan-Chiu, E., Ford, L., Wolmark, N., and other National Surgical Adjuvant Breast and Bowel Project Investigators (1998) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-l Study. J. Natl. Cancer Inst. 18: 1371-1388 |
19 | Ambs, S., Hussain, S. P., and Harris, C. C. (1997) Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression. FASEB J. 11: 443-448 |
20 | Marton, L. J. and Pegg, A. E. (1995) Polyarnines as targets for therapeutic intervention. Annu. Rev. PhamUlcol. Toxicol. 35: 55-91 DOI ScienceOn |
21 | Tschugguel, W., Knogler, W., Czerwenka, K., Mildner, M., Weninger, W., Zeillinger, R., and Huber, J. C. (1996) Presence of endothelial calcium-dependent nitric oxide synthase in breast apocrine metaplasia. Br. J. Cancer 74: 1423-1426 DOI ScienceOn |